Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  256,033 results for ""Antibodies""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Antibodies.
Research Starter

Antibodies.

  • Antibodies are proteins produced by the B lymphocyte white blood cells of the immune system of human and nonhuman animals ... More
  • Salem Press Encyclopedia of Health, 2023. 3p.
Academic Journal

Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy.

  • Authors : Huang C; Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA.; Waduge P

Subjects: Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/drug therapy ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/metabolism ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/immunology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 01; Vol. 25 (17). Date of Electronic Publication: 2024 Sep 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Efficacy of Combination of Antiviral Therapy With Neutralizing Monoclonal Antibodies for Recurrent Persistent SARS-CoV-2 Pneumonia in Patients With Lymphoma.

  • Authors : Gai X; Department of Pulmonary and Critical Care Medicine Peking University Third Hospital, Beijing 100083, China.; Sun X

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology

  • Source: BioMed research international [Biomed Res Int] 2024 Aug 06; Vol. 2024, pp. 8182887. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.

  • Authors : Kister I; NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.; Curtin R

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Jul; Vol. 11 (7), pp. 1750-1764. Date of Electronic Publication: 2024 May 07.Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1.

  • Authors : Xu J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.; Laboratory of Lymphocyte Nuclear Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, 20892, USA.

Subjects: HIV-1*/HIV-1*/HIV-1*/immunology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/immunology ; Camelids, New World*/Camelids, New World*/Camelids, New World*/immunology

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Jul; Vol. 11 (26), pp. e2309268. Date of Electronic Publication: 2024 May 05.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire.

  • Authors : Altman PX; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.

Subjects: HIV Antibodies*/HIV Antibodies*/HIV Antibodies*/immunology ; AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/immunology ; HIV-1*/HIV-1*/HIV-1*/immunology

  • Source: PLoS pathogens [PLoS Pathog] 2024 Sep 09; Vol. 20 (9), pp. e1012042. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants.

  • Authors : Ye G; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.; Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota, United States of America.

Subjects: Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/immunology ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/metabolism ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2024 Sep 05; Vol. 20 (9), pp. e1012493. Date of Electronic Publication: 2024 Sep 05 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Post-Hoc Analysis of Potential Correlates of Protection of a Recombinant SARS-CoV-2 Spike Protein Extracellular Domain Vaccine Formulated with Advax-CpG55.2-Adjuvant.

  • Authors : Petrovsky N; Vaxine Pty Ltd., Warradale, Adelaide 5046, Australia.; Australian Respiratory and Sleep Medicine Institute, Adelaide 5042, Australia.

Subjects: Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 30; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults.

  • Authors : Tunheim G; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway. .; Fossum E

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood SARS-CoV-2 variants

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Aug 20; Vol. 24 (1), pp. 841. Date of Electronic Publication: 2024 Aug 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Immunogenicity, clinical efficacy, and safety of the sinopharm (BBIBP-CorV) SARS-CoV-2 vaccine among people with multiple sclerosis receiving disease-modifying therapies: a prospective cohort study.

  • Authors : Jameie M; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, 1419733141, Iran.; Azizmohammad Looha M

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: BMC neurology [BMC Neurol] 2024 Aug 20; Vol. 24 (1), pp. 291. Date of Electronic Publication: 2024 Aug 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Recombinant Subunit Vaccine Candidate against the Bovine Viral Diarrhea Virus.

  • Authors : Avello V; Biotechnology and Biopharmaceuticals Laboratory, Pathophysiology Department, School of Biological Sciences, Universidad de Concepción, Víctor Lamas 1290, Concepción P.O. Box 160C, Chile.; Salazar S

Subjects: Viral Vaccines*/Viral Vaccines*/Viral Vaccines*/immunology ; Vaccines, Subunit*/Vaccines, Subunit*/Vaccines, Subunit*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 10; Vol. 25 (16). Date of Electronic Publication: 2024 Aug 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  256,033 results for ""Antibodies""